Evelo Biosciences, Inc. (EVLO) Financials
EVLO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 20.6 million | 47.3 million |
2023-06-30 | 20.8 million | 66.9 million |
2023-03-31 | 42.0 million | 69.4 million |
2022-12-31 | 64.4 million | 69.4 million |
EVLO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -10.5 million | 2.5 million |
2023-06-30 | -19.8 million | 2.4 million |
2023-03-31 | -20.3 million | 2.9 million |
2022-12-31 | -23.4 million | 3.4 million |
EVLO Net Income
No data available :(
EVLO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 17.3 million | - | - |
2023-06-30 | 7.6 million | - | 6.6 million |
2023-03-31 | 27.5 million | - | 6.9 million |
2022-12-31 | 47.9 million | - | 7.5 million |
EVLO Shares Outstanding
EVLO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 47000 | 6.5 million | 3.9 million | - |
2023-06-30 | - | 13.0 million | 4.9 million | - |
2023-03-31 | 12000 | 17.9 million | 7.0 million | - |
2022-12-31 | 228000 | 16.1 million | 5.0 million | - |
EVLO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 793000 |
2023-06-30 | - | 1.6 million |
2023-03-31 | - | - |
2022-12-31 | - | - |
EVLO
Price: $0.04
52 week price:
Earnings Per Share: -15.64 USD
P/E Ratio: -1.81
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 71715
Market Capitalization: 778294